Hiberiks

Composition Hiberiks

1 dose Hiberiks  Dose Hiberiks
   contains 10 micrograms of the capsular polysaccharide isolated from Hib strain 20 752 containing about 30 ug tetanus toxoid. As excipients used are: lactose - 10, 08 mg of 1 dozu.Rastvoritel: Sodium Chloride 0, 9% - 0, 5 ml per 1 dose.

Description

Hiberiks a vaccine against Haemophilus influenzae (B), is produced in the form of a powder or of a white or grayish white color.

Indications Hiberiksa

Hiberiks used for preventing Haemophilus influenzae type b in children ranging from the age of 6 weeks and 5 years. Hiberiks has no preventive effect on other types of Haemophilus influenzae bacterial meningitis and other etiologies.

Contraindications

Hypersensitivity of the components of the vaccine, including tetanus toxoid. An allergic reaction to the previously vaccine Haemophilus influenzae (B).

In acute diseases - infectious and non-communicable and chronic diseases in the acute stage of vaccination is acceptable for at least a month after recovery. For treatment of respiratory, intestinal and other infections that occur in mild form of vaccination is acceptable, subject to the normalization of body temperature.

Patients with HIV infection is allowed to use Hiberiks.

Hiberiks Dosage and instructions for use

Age from 6 weeks to 6 months: the vaccine consists of three repetitions at intervals of 1, or 1, 5, or 2 months. Different countries have adopted different vaccination schedules. Revaccination is carried out once in the second year zhizni.Rekomenduetsya Hiberiks combine vaccination with vaccination against whooping cough, polio, tetanus and diphtheria.

Age from 6 months to a year: the vaccine consists of two repetitions at intervals of 1 month. Re-vaccination is done once in the second year of life. Acceptable combination Hiberiksom vaccination with vaccination against whooping cough, polio, tetanus, rubella, diphtheria, mumps and measles.

Age from 1 year to 5 years: is a one-time vaccination, the vaccine is made intramuscularly. Patients with abnormalities of blood coagulation is administered subcutaneously.

Before using Hiberiksa should carefully examine the attached solvent for the presence of foreign particles, or change in appearance. In identifying the physical particles or discoloration of the solution can not be used.

Before using Hiberiksa being complete solution was added to the vial with a vaccine based 0, 5 ml per 1 dose. The drug is mixed by shaking. Generally, to completely dissolve the lyophilisate sufficiently less than one minute. After the dissolution of the drug looks like a transparent colorless liquid. If after mixing of the preparation revealed undissolved particles or the color does not correspond to that described, such a drug can be used. After opening the bottle the drug should be used within one working day. Residues should be disposed of.

Adverse reactions Hiberiksa

After the introduction of  Packing Hiberiks
 Vaccine Hiberiksa feedback from physicians suggest the possibility of minor injection site redness, swelling and pain, usually not more than 48 hours.

It is also possible manifestation in the next 48 hours: fever, loss of appetite, restlessness, vomiting, diarrhea. Similar reactions were also recorded while vaccination with other vaccines.

According to reviews Hiberiks may cause other reactions to vaccines, such as:

• allergic reactions (anaphylaxis and anaphylactoid), angioedema;

• hypotonic-hyporesponsiveness episode, syncope, seizures (with or without fever), drowsiness;

• Apnea;

• swelling of the limbs at the injection site, local induration;

• hives, rash.

Interaction with other drugs Hiberiksa

Acceptable Hiberiksa administration with other vaccines. In patients receiving immunosuppressive therapy may not be obtained the desired immune response.

Cautions

Due to the occurrence probability in the rare cases of anaphylactic reactions following vaccination patient must remain under medical observation for at least 30 minutes. It is strictly forbidden to intravenous administration Hiberiksa!

After the premature infants vaccinated Hiberiksom instruction recommended to monitor their respiratory functions within 48-62 hours.

storage conditions

Shelf life substance vaccine Hiberiks - 3 years. The drug expired recyclable. The vaccine stored at 2 - 8 ° C in the dark place. The drug should not be frozen. Keep the vaccine should be out of the reach of children.





Яндекс.Метрика